RiceBran Technologies (NASDAQ: RBIT) is a human food ingredient and animal nutrition company focused on the procurement, bio-refining and marketing of numerous products derived from rice bran. The company’s proprietary and patented intellectual property allows it to convert rice bran, … Continue reading →

The Pulse Beverage Corp. (OTCQBL PSLB) is focused on becoming a market leader in the development and marketing of nutritional/functional beverage products that provide real health benefits to a significant segment of the population and are convenient and appealing to … Continue reading →

Celator Pharmaceuticals, Inc. (NASDAQ: CPXX) is focused on developing new and more effective therapies to treat cancer. CombiPlex®, the company’s proprietary drug ratio technology platform, represents a novel approach that identifies molar ratios of drugs that will deliver a synergistic … Continue reading →

Stellar Biotechnologies, Inc. (OTCQB: SBOTF) is a commercialization stage company focused in the immunotherapy arena, with world-leading technology in Keyhole Limpet Hemocyanin (KLH) protein. KLH is an important immune-stimulating molecule widely used as a key active ingredient in many new … Continue reading →

Sanuwave Health, Inc. (OTCBB: SNWV) is developing and commercializing patented devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures. Sanuwave’s portfolio of regenerative medicine products and candidates are based on the company’s patented PACE technology for … Continue reading →

DecisionPoint Systems, Inc. (NASDAQ: DPSI) is an enterprise systems integrator that provides improved productivity and operational advantages to its clients by helping them move their business decision points closer to their customers. Using mobile computing technologies, DecisionPoint designs, develops, deploys … Continue reading →

Soligenix, Inc. (OTCBB: SNGX) is a clinical stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix’s therapeutics segment is dedicated to the development of products … Continue reading →

Ellomay Capital Ltd. (NYSE: ELLO) is an Israeli-based company operating in the global energy and infrastructure sectors. To date, Ellomay has invested significant funds in the renewable and clean energy power plants in Israel, Italy and Spain, including approximately 22.6 … Continue reading →

Boston Therapeutics, Inc. (OTCQB: BTHE) addresses unmet medical needs in diabetes and inflammatory diseases through the development, manufacturing and commercialization of novel compounds based on complex carbohydrate chemistry. The company’s initial product is comprised of: BTI320, a chewable drug candidate … Continue reading →

Hipcricket, Inc. (OTCBB: HIPP) provides a unified mobile engagement platform designed to promote awareness, sales and loyalty. The company’s AD LIFE® platform has been used by internationally recognized brands and agencies to power more than 400,000 campaigns across SMS, 2D/QR … Continue reading →